SCHEMBL29733060

SCHEMBL29733060

CCCCCCCCCCCCCCc1cc(OC2CCC2)nc(N2CCC2)n1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 1/20 0.44
▸ HTR1A P08908 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ HTR7 P34969 1/20 0.37
▸ HTR6 P50406 1/20 0.37
▸ FFAR4 Q5NUL3 6/20 0.35
▸ KCNH2 Q12809 1/20 0.33
▸ HRH4 Q9H3N8 1/20 0.33
▸ EHMT2 Q96KQ7 1/20 0.33
▸ EHMT1 Q9H9B1 1/20 0.33
▸ CDK1 P06493 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ NPY5R Q15761 1/20 0.32
▸ GBA1 P04062 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19899742 1.00 PDE10A (0.44) PDE10AHTR1ADRD2HTR2AHTR7
SCHEMBL18005467 1.00 PDE10A (0.44) PDE10AHTR1ADRD2HTR2AHTR7
SCHEMBL18005408 0.98 PDE10A (0.46) PDE10AHTR1ADRD2HTR2AHTR7
SCHEMBL18005482 0.96 PDE10A (0.46) PDE10AHTR1ADRD2HTR2AHTR7
SCHEMBL18005631 0.84 HTR1A (0.40) PDE10AHTR1ADRD2HTR2AHTR7
SCHEMBL18005335 0.83 HTR1A (0.40) PDE10AHTR1ADRD2HTR2AHTR7
SCHEMBL18029842 0.83 HTR1A (0.40) PDE10AHTR1ADRD2HTR2AHTR7
SCHEMBL19899798 0.82 KCNH2 (0.38) FFAR4KCNH2CDK1CDK2
SCHEMBL19900149 0.82 KCNH2 (0.38) FFAR4KCNH2CDK1CDK2
SCHEMBL19900123 0.81 HRH4 (0.40) PDE10ADRD2HTR6FFAR4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595250-B2 Substituted pyrimidine compounds as multifunctional radical quenchers and their uses ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2026-04-07 — — US disclosed
US-20220324841-A1 THERAPEUTIC COMPOUNDS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2022-10-13 — — US disclosed
US-11390605-B2 Substituted pyrimidine compounds as multifunctional radical quenchers and their uses ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2022-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595250-B2 Substituted pyrimidine compounds as multifunctional radical quenchers and their uses GSR, UQCRC1, TXNRD2 PDE10A 2815/4885HTR1A 1311/4885DRD2 1585/4885
US-20220324841-A1 THERAPEUTIC COMPOUNDS CFTR, F12, FURIN PDE10A 991/4885HTR1A 3084/4885DRD2 2738/4885
US-11390605-B2 Substituted pyrimidine compounds as multifunctional radical quenchers and their uses DPYD, TYMP, NUDT1 PDE10A 1997/4885HTR1A 1210/4885DRD2 1476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback